UBS U.S. Large Cap Growth A (BNLGX) was incepted in December 1998. The investment seeks long-term capital appreciation.
The fund invests in the stocks of large companies with market-capitalization values generally of at least $6 billion at the time of purchase. In addition, it may invest up to 20% of its assets in foreign securities. The fund is non-diversified.
Allergan Inc. (AGN), Visa Inc. (V) and Qualcomm Inc. (QCOM) are among the top holdings at the fund.
UBS Global Equity A (BNGEX) seeks to maximize total US dollar return, consisting of capital appreciation and current income.
The fund invests in a diversified portfolio of US and foreign equities, primarily large capitalization stocks of major developed countries. It utilizes a globally integrated investment process intended to uncover undervalued markets, currencies, sectors and securities.
Nicholas Melhuish has been lead manager at the fund since January 2008. The fund has an expense ratio of 1.25%.
UBS PACE Government Securities Fixed Income A (PFXAX) seeks current income. The fund primarily invests in government fixed income securities.
While it can invest in US government and other bonds of varying maturities, the fund normally limits portfolio “duration” within two years of the effective duration of its benchmark index. As of January 2009, its portfolio turnover was 970%.
Unit holders have to make a minimum initial investment of $1,000 to enter this Zacks#1 Rank (“Strong Buy”) fund. The fund has topped the total returns of its benchmark index in the last 1-, 3- and 5-year periods.
